JAK2 and neoplasm: Experimental evidence revealed that XCHT suppressed tumor growth by downregulating the TLR4/MyD88/NF-κB and IL-6/JAK2/STAT3 signaling pathways and improving the tumor immune microenvironment 251, 252.